Free Trial

ADC Therapeutics (ADCT) Earnings Date, Estimates & Call Transcripts

ADC Therapeutics logo
$2.39 -0.26 (-9.81%)
(As of 11/15/2024 ET)

ADC Therapeutics Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 12Estimated
Actual EPS
(Nov. 7)
-$0.42 Missed By -$0.06
Consensus EPS
(Nov. 7)
-$0.36

ADC Therapeutics released Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.42, which missed the consensus estimate of -$0.36 by $0.06. Quarterly revenue was reported to be $18.46 million, below analysts' expectations of $18.76 million. With a trailing EPS of -$2.39, ADC Therapeutics' earnings are expected to grow next year, from ($1.68) to ($1.32) per share.

ADCT Upcoming Earnings

ADC Therapeutics' next earnings date is estimated for Wednesday, March 12, 2025, based off prior year's reporting schedules.

Get ADC Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ADC Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ADCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ADC Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.56-$0.56-$0.56
Q2 20241-$0.58-$0.58-$0.58
Q3 20242-$0.59-$0.31-$0.45
Q4 20242-$0.60-$0.35-$0.48
FY 20246-$2.33-$1.80-$2.07
Q1 20251-$0.29-$0.29-$0.29
Q2 20251-$0.31-$0.31-$0.31
Q3 20251-$0.35-$0.35-$0.35
Q4 20251-$0.36-$0.36-$0.36
FY 20254($1.31)($1.31)($1.31)

ADC Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/12/2025
(Estimated)
------- 
11/7/2024Q3 2024-$0.36-$0.42 -$0.06-$0.42$18.76M$18.46M        
8/6/2024Q2 2024-$0.44-$0.38+$0.06-$0.38$19.06M$17.41M        
5/6/2024Q1 2024-$0.56-$0.56--$0.56$18.19M$18.05M        
3/13/2024Q4 2023-$0.47-$1.03 -$0.56-$1.03$16.58M$16.79M
11/7/2023Q3 2023-$0.61-$0.58+$0.03-$0.58$14.57M$14.49M    
8/8/2023Q2 2023-$0.44-$0.58 -$0.14-$0.58$34.77M$19.28M    
5/9/2023Q1 2023-$0.80-$0.74+$0.06-$0.74$20.10M$18.99M    
2/28/2023Q4 2022-$0.49-$0.30+$0.19-$0.30$75.53M$69.80M    

ADC Therapeutics Earnings - Frequently Asked Questions

ADC Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates. Learn more on ADCT's earnings history.

In the previous quarter, ADC Therapeutics (NYSE:ADCT) missed the analysts' consensus estimate of ($0.36) by $0.06 with a reported earnings per share (EPS) of ($0.42). Learn more on analysts' earnings estimate vs. ADCT's actual earnings.

The conference call for ADC Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for ADC Therapeutics's latest earnings report can be read online.
Read Transcript

ADC Therapeutics (NYSE:ADCT) has a recorded annual revenue of $69.56 million.

ADC Therapeutics (NYSE:ADCT) has a recorded net income of -$240.05 million. ADCT has generated -$2.39 earnings per share over the last four quarters.

ADC Therapeutics's earnings are expected to grow from ($1.68) per share to ($1.32) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NYSE:ADCT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners